Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01782703 · ClinicalTrials.gov registry record
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
A clinical trial of Atopic Dermatitis and Eczema, sponsored by Northwestern University.
- Active
- Registry status
- 505
- Enrollment target
- 4
- Study locations
NCT01782703 is a study of Atopic Dermatitis and Eczema that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 505 participants, below the 606-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (17% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT01782703, a study of Atopic Dermatitis and Eczema, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- 505 participants
- Enrollment target
- 4
- Study locations
Study Summary
Atopic dermatitis (AD), also known as eczema, is the most common inflammatory skin disorder of children, affecting 10-20% of children and 1-2% of adults. This skin disorder can be associated with unbearable itchiness and an increased susceptibility to skin infections. The cause of AD is currently poorly understood; therefore, there are no targeted treatment options at present. There have been recent studies in adults with AD that explain the cause and give us new routes to investigate treatment options, however no major studies in this arena have been done in children. We hope to evaluate the skin and blood biomarkers that are found in pediatric AD and compare them to adult AD. Hypothesis: The immune system worsens the skin barrier issues that are common in atopic dermatitis. We believe there are similar immune and skin abnormalities in adult versus pediatric atopic dermatitis. Finally, blood levels of the activated molecules in atopic dermatitis can serve as surrogates for skin immune activation and will correlate with disease severity.
Conditions Studied
Study Locations (4)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- Northwestern University - Chicago
- Northbrook Lurie Children's Outpatient Clinic - Northbrook
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2013-01 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01782703
The ClinicalTrials.gov registry entry for NCT01782703 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 505 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 606-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (17% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 0 interventions.
NCT01782703 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT01782703 about?
NCT01782703 is a clinical study titled "Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis". Atopic dermatitis (AD), also known as eczema, is the most common inflammatory skin disorder of children, affecting 10-20% of children and 1-2% of adults. This skin disorder can be associated with unbearable itchiness and an increased susceptibility to skin infections. The cause of AD is currently p...
What is the current status of trial NCT01782703?
This trial is currently active not recruiting. The enrollment target is 505 participants. The study started on 2013-01. Estimated completion is 2025-12.
What conditions does trial NCT01782703 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Eczema.
Who is sponsoring clinical trial NCT01782703?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01782703 being conducted?
This trial has 4 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.